Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety Publisert: 01.04.2025 Navamedic ASA: Letter received from the Norwegian Financial Supervisory Authority Publisert: 28.03.2025 Navamedic ASA: Mandatory notice of trade Publisert: 19.03.2025 Navamedic ASA: Mandatory notice of trade Publisert: 10.03.2025 Navamedic ASA: Mandatory notice of trade Publisert: 14.02.2025 Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives Publisert: 12.02.2025 FørsteForrige1112131415NesteSiste
Navamedic ASA: Letter received from the Norwegian Financial Supervisory Authority Publisert: 28.03.2025
Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives Publisert: 12.02.2025